PubMed

Shoulder arthroplasty device clearance: an ancestral network analysis.

PMID: 36279987 · 2022-10-21

A, n, d, r, e, w, , Z, h, u, ;, , X, i, a, o, h, a, n, , Y, i, n, g, ;, , E, d, w, a, r, d, , G, , C, a, r, e, y, ;, , C, h, r, i, s, t, i, a, n, , A, , P, e, a, n, ;, , A, j, a, y, , P, r, e, m, k, u, m, a, r, ;, , M, i, c, h, a, e, l, , C, , F, u, ;, , S, a, m, u, e, l, , A, , T, a, y, l, o, r

ЖурналJournal of shoulder and elbow surgery

Год2022-10-21

PMID36279987

Аннотация

The US Food and Drug Administration (FDA) oversees medical device regulation and oversight in the United States, and the majority of shoulder arthroplasty devices are cleared via the 510(k) pathway, in which a device demonstrates "substantial equivalence" to a previously cleared predicate. The purpose of this study was to determine an interconnected ancestral network of shoulder arthroplasty devices and determine equivalency ties to devices subsequently recalled by the FDA for design-related iss

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.